Edesa Biotech Reports Fiscal Year 2024 Results
December 13, 2024 16:30 ET
|
Edesa Biotech, Inc.
TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
ViaDerma Announces Significant 2024 Achievements and International Expansion
December 10, 2024 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Dec. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM), an innovator in transdermal drug delivery and topical antibiotic products, proudly announces the completion of a...
Dermatology Treatment and Care Research Report 2024-2030 with Analyst Recommendations - Tapping into the Demand for Tailored Solutions / Focus on Expansion in Emerging Markets
October 29, 2024 05:01 ET
|
Research and Markets
Dublin, Oct. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Dermatology Treatment and Care Market (2024 Edition): Analysis By Treatment Type (Skin Disease and Care, Hair Disease and Care), By Route of...
ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow Growth
October 03, 2024 08:00 ET
|
ViaDerma, Inc.
ViaDerma post strong Q2 results
U.S. Dermatology Imaging Devices Market Report 2024-2030: Digital Photographic Imaging, OCT, Dermatoscope, Skin Cancers, Inflammatory Dermatoses Size, Share & Trends Analysis
September 09, 2024 07:34 ET
|
Research and Markets
Dublin, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The "U.S. Dermatology Imaging Devices Market Size, Share & Trends Analysis Report By Modality (Digital Photographic Imaging, OCT, Dermatoscope), By...
ViaDerma Announces Shipment of 500,000 Units of its Flagship Product to Nigeria
August 13, 2024 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Aug. 13, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a leader in innovative wound care solutions, is excited to announce that a shipment of 500,000 units of its flagship...
ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires
August 01, 2024 08:00 ET
|
ViaDerma, Inc.
ViaDerma announces strategic new agreements to move forward its global expansion.
Dermatitis Global Market Report 2024: Analysis Reveals Key Trends in Biologics and Personalized Medicine Approaches - Long-term Forecasts to 2028 and 2033
January 26, 2024 03:32 ET
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Dermatitis Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. There is significant growth underway in the global...
ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More
October 24, 2023 10:30 ET
|
ViaDerma, Inc.
LOS ANGELES, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce several new and exciting business updates for current and prospective shareholders,...
ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More
July 06, 2023 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, July 06, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is very pleased to announce several exciting business updates for current and prospective shareholders, partners, and...